35
Views
1
CrossRef citations to date
0
Altmetric
Review

Economics of family planning and birth control

Pages 23-28 | Published online: 09 Jan 2014

References

  • Anon. The Pill: avoiding misconceptions. The Economist, 13th October, (2001).
  • Anon. History of birth control. Encylopaeclia Britannica (2002).
  • Anon. Contraception. Encylopaeclia Britannica (2002).
  • Anon. Social and political aspects of birth control. Encylopaeclia Britannica (2002).
  • Anon. The future of contraception: a pregnant pause. The Economist, 13th October, (2001).
  • Toulemon L, Leridon H. Contraceptive practices and trends in France. Family Planning Penpectives 30,114–120 (1998).
  • McGuire A, Hughes D. The economics of family planning services: a report prepared for the Contraceptive Alliance. Family Planning Association, London, UK (1995).
  • Phillips CJ. Economic analysis of long-term reversible contraceptives: focus on Implanon. PharmacoEconomics 17, 209–221 (2000).
  • •Considers the costs and benefits from investing in long-term contraceptives, which are not reliant on user compliance.
  • Klima CS. Unintended pregnancy: consequences and solutions for a worldwide problem. I Nurse Nlich44fery 43,483–491 (1998).
  • Koenig JD, Strauss MJ, Henneberry J, Wilson TG. The social costs of inadequate contraception. Int. J. Technol Assess. Healthcare 12, 487–497 (1996). iiKinghorn G. A sexual health and HIV strategy for England. BE Med. 1). 323,243-244 (2001).
  • The Health of the Nation. A strategy for health in England. HMSO, London, UK (1992).
  • Office of National Statistics, Abortion Statistics. HMSO London, UK (1996).
  • Kaminsky M, Crost M, Garel M. Les IVG répkées en France: analyse des bulletins statistiques d'IVG. Contracept. Fertil Sex 25(2), 152–158 (1997).
  • The National Board of Health and Welfare, Centre for Epidemiology. Statistics - health and diseases: abortions in Sweden 1997 (Jan-Dec). Stockholm: The National Board of Health and Welfare, Centre for Epidemiology, Sweden (1998).
  • Larsson G, Blohm F, Sundell G, Andersch B, Milsom I. A longitudinal study of birth control and pregnancy outcome among women in a Swedish population. Contraception 56,9–16 (1997).
  • Edwards J, Moore A. Implanon: a review of clinical studies. BE J. Family Ranning24(4 Suppl.) 3–16 (1999).
  • •A systematic review of studies undertaken to assess the effectiveness of one contraceptive method.
  • Adams Hillard PJ. Oral contraception noncompliance: the extent of the problem. Adv Contracept. 8 (Suppl. 1), 13–20 (1992).
  • Harlap S, Kost K, Forrest JD. Preventing pregnancy, protecting health: a new look at birth control in the United States. Alan Guttmacher Institute, New York, USA (1991).
  • Litt IF, Cluskey WR, Rudd S. Identifying adolescents at risk for non-compliance with contraceptive therapy. I Pediatrics 96,742–745 (1980).
  • Litt IF. Know thyself - adolescents' self- assessment of compliance with contraceptive therapy. Pediatrics 75,693–96 (1985).
  • Cromer BA, Smith RD, Blair JM et al A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception. Pediatrics 94,687–694 (1994).
  • Martin RM, Hilton SR, Kerry SM. The impact of the October 1995 'pill scare' on oral contraceptive use in the UK: analysis of a general practice automated database. Fain. Pract. 14,279-284 (1997).
  • Rosser M, Stone BS, Graves W, Hatcher R. Depo-Provera: an excellent contraceptive for those who continue to use it. Prim. Care Update Ob. Gyris. 5,172 (1998).
  • Croxatto HB, Makarainen L. The pharmacodynamics and efficacy of Implanon: an overview of the data. Contraception 58,91S-97S (1998).
  • Sivin I, Mishell DR, Darney P et al Levonorgestrel capsule implants in the United States: a 5-year study. Obstet. Gynecol. 92,337-344 (1998).
  • Bandolier. Hormonal IUD. Bandolier 35.
  • Anderson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomised comparative trial. Contraception 49,56–72 (1994).
  • Chi I. The TCu 380A (Ag), MLCu375 and Nova T IUDs and the IUD daily releasing 20pg levonorgestrel - four pillars of IUD contraception for the nineties and beyond? Contraception 47,325–347 (1993).
  • Mascarenhas L. Insertion and removal of Implanon. Contraception 58,79S-83S (1998).
  • McGuire A. The economics of healthcare: an introductory text. Routledge and Kegan Paul, London, UK (1988).
  • Gerard K. Cost-utility in practice: a policy maker's guide to the state of the art. Health Polig,21, 249–279 (1992).
  • Serafty D. Contraception. Paris, France: Masson, 1998 (Series: Abrégés)
  • Department of Health. The national strategy for sexual health and HIV Department of Health, London, UK (2001).
  • Burkman RT, Sonnenberg FA. Health economics of contraception. Obstet. Gynecol. Clin. North Am. 27,917–931 (2000).
  • Trussell J, Koenig J, Ellerston C, Stewart Preventing unintended pregnancy: the cost-effectiveness of three methods of emergency contraception. Am J. Public Health 87, 932–937 (1997).
  • Trussell J, Leveque JA, Koening JD et al The economic value of contraception: a comparison of 15 methods. Am. J. Public Health 85,494–503 (1995).
  • •A useful overview of the effectiveness and cost-effectiveness of contraceptive methods.
  • Trussell J, Koening J, Stewart F, Darroch JE. Medical care cost savings from adolescent contraceptive use. Family Planning Perspectives 29,248–255; 295 (1997).
  • Ortmeier BG, Sauer IKA, Langley PC, Bealmear BK. A cost-benefit analysis of four hormonal contraceptive methods. Clin. Tiler. 16,707–713 (1994).
  • Anon. Contraception in poor countries: a fertile future? The Economist, 13th October, (2001).
  • Trussell J, Hatcher RA, Cates W, Jr., Stewart FH, Kost K. Contraceptive failure in the United States: an update. Stud. Fain. Plana. 21,51–54 (1990).
  • Trussell J, Hatcher RA, Cates W, Jr., Stewart FH, Kost K. A guide to interpreting contraceptive efficacy studies. Obstet. Gynecol. 76(3 Pt 2), 558–567 (1990).
  • Department of Health. Health Survey for England 1995. Volume I: Findings. HMSO, London, UK 254–255 (1996).
  • Sivin I. Progestogen-only contraception. Medicine 25,5–7 (1997).
  • Meckstroth KR, Darney PD. Implantable contraception. Obstet. Gynecol Clin. North Am 27,781–815 (2000).

Websites

  • Phillips CJ, Thompson G. What is cost effectiveness? London: Hayward Medical Publications, 1997 (available at www.jR2.ox.ac.uldbandolieripainreil download/whatis/whatis.html)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.